Reopening Laboratory Research at SMHS
Reopening Laboratory Research at SMHS
Augmenting the research portfolio and elevating its prominence through enhanced quality and impact.
These facilities offer a wide range of services, including cutting-edge technologies and high-end instrumentation coupled with technical support for research.
Coronavirus (COVID-19) Update: SMHS Research Re-Start PlansReopening Laboratory Research at SMHS
Plans for Reopening Laboratory Research at SMHS
Roster for SMHS Reopening Committees
Visit GW SMHS ON CAMPUS Policies and Guidelines website
Reopening Laboratory Research at SMHS
Four young researchers at the GW School of Medicine and Health Sciences were selected as fellows to the recently awarded five-year National Cancer Institute T32 Training Grant.
The retrospective study from a team at GW found that spironolactone may be safe to treat female pattern hair loss in breast cancer survivors.
Investigators at SMHS received a $1.2 million grant from Wellcome Trust to produce a controlled human hookworm infection model and establish a hookworm vaccine challenge model for two of the most advanced hookworm vaccine candidate antigens in endemic areas.
